Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Azurity Pharmaceuticals, Inc.
FDA Inspection
•Azurity Pharmaceuticals, Inc.•February 19, 2025

Azurity Pharmaceuticals, Inc. – FDA Inspection, Feb 19, 2025

Record Details

This FDA Inspection record concerns Azurity Pharmaceuticals, Inc., with an inspection on February 19, 2025, issued by the New England District Office, covering human drugs.

Company
Azurity Pharmaceuticals, Inc.
Inspection Date
February 19, 2025
Product Type
Human Drugs
Office
New England District Office
People
  • Armen H. Youssoufian (Issuing Officer)
  • Erik W. Koester (FDA Associated Person)
View Company Profile

ID · 5bc3e1cb-551b-4b19-8657-c5a1e0e2c087

Inspection Facts

Inspection number
1261303
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

1
  1. 21 CFR 211.198(a)Complaint Handling Procedure

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Azurity Pharmaceuticals, Inc.

8
DateClassificationOfficeProject area
December 12, 2025NAIDrug Quality Assurance
March 2, 2023Not classifiedNew England District OfficeDrug Quality Assurance
February 24, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 26, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 20, 2017Not classifiedNew England District Office
View all 8 other inspections on the company page
Other documents for Azurity Pharmaceuticals, Inc.
  • FDA Inspection 1297348 - 2025-12-12
  • FDA Inspection 1199279 - 2023-03-02
  • FDA Inspection 1163010 - 2022-02-24
  • FDA Inspection 1100022 - 2019-07-26
  • FDA Inspection 1038444 - 2017-12-20

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Azurity Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.